Community-acquired pneumonia in elderly patients: the effectiveness of antimicrobial therapy regimens. | Zendy

I. Ts. Kulagina | Zendy; V I Likhodii | Zendy; А. А. Зайцев | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Community-acquired pneumonia in elderly patients: the effectiveness of antimicrobial therapy regimens.

Author(s) -

I. Ts. Kulagina,

V I Likhodii,

А. А. Зайцев

Publication year - 2019

Publication title -

bulletin of the russian military medical academy

Language(s) - English

Resource type - Journals

eISSN - 2687-1424

pISSN - 1682-7392

DOI - 10.17816/brmma20686

Subject(s) - medicine , community acquired pneumonia , amoxicillin , pneumonia , sulbactam , radiological weapon , intensive care medicine , antibiotics , antimicrobial , surgery , antibiotic resistance , chemistry , organic chemistry , imipenem , microbiology and biotechnology , biology

The clinical efficacy of using «protected» aminopenicillins (amoxicillin/clavulanate, amoxicillin/sulbactam) and the 3rd generation cephalosporins in the treatment of mild community-acquired pneumonia in patients older than 60 years in hospital has been evaluated. Analyzed 71 case histories. The assessment was carried out on the basis of a comprehensive analysis of clinical, laboratory and radiological data. A comparative analysis of the clinical efficacy and safety of the antibiotic regimens under study demonstrated the obvious advantage of using «protected» aminopenicillins over the existing practice of treating non-severe community-acquired pneumonia in patients of older age groups.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research